MX2018015607A - Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad. - Google Patents

Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad.

Info

Publication number
MX2018015607A
MX2018015607A MX2018015607A MX2018015607A MX2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A MX 2018015607 A MX2018015607 A MX 2018015607A
Authority
MX
Mexico
Prior art keywords
skin
microstructure
hyaluronic acid
solubility characteristics
present
Prior art date
Application number
MX2018015607A
Other languages
English (en)
Inventor
Soo Kim Jae
Chang Kwon Soon
Jin Park Sang
Original Assignee
Endoderma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endoderma Co Ltd filed Critical Endoderma Co Ltd
Publication of MX2018015607A publication Critical patent/MX2018015607A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Cosmetics (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

La presente invención se refiere a una microestructura de ácido hialurónico que tiene excelentes características de solubilidad. Más específicamente, la presente invención se refiere a una microestructura biodegradable que comprende ácido hialurónico reticulado y que tiene excelentes características de solubilidad durante la penetración en la piel. Cuando la microestructura de la presente invención es penetrada en la piel, las características de solubilidad en la piel son excelentes, la velocidad de disolución en la piel se puede controlar fácilmente de acuerdo con la relación de contenido del ácido hialurónico reticulado, y, mientras que los ingredientes efectivos proporcionados en la microestructura se pueden administrar de manera estable en la piel, la velocidad de liberación de los ingredientes efectivos proporcionados se puede controlar fácilmente y, por lo tanto, la presente invención se puede usar como un sistema de suministro transdérmico para materiales farmacológicamente activos o materiales para mejorar la piel.
MX2018015607A 2016-06-16 2017-06-16 Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad. MX2018015607A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160074985 2016-06-16
PCT/KR2017/006342 WO2017217818A1 (ko) 2016-06-16 2017-06-16 용해 특성이 우수한 히알루론산 마이크로구조체

Publications (1)

Publication Number Publication Date
MX2018015607A true MX2018015607A (es) 2019-03-14

Family

ID=60663275

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018015607A MX2018015607A (es) 2016-06-16 2017-06-16 Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad.

Country Status (9)

Country Link
US (1) US11013670B2 (es)
EP (1) EP3473242A4 (es)
JP (1) JP6900405B2 (es)
KR (1) KR101973801B1 (es)
CN (1) CN109310625A (es)
BR (1) BR112018075703A2 (es)
MX (1) MX2018015607A (es)
TW (2) TWI675666B (es)
WO (1) WO2017217818A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102025546B1 (ko) 2017-11-22 2019-09-26 단국대학교 천안캠퍼스 산학협력단 히알루론산-칼슘 복합체 및 알지네이트를 포함하는 약물 전달체
TR201922945A2 (tr) * 2019-12-31 2021-07-26 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Osteoartri̇t tedavi̇si̇ i̇çi̇n propoli̇s i̇çeri̇kli̇ yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇
EP3854375A1 (en) * 2020-01-23 2021-07-28 Paean Aesthetics Inc Micro-spicule composition to control its shape and method for producing the same
US11129788B1 (en) * 2020-03-24 2021-09-28 Elc Management Llc Sprayable film forming compositions for improving the performance of topical preparations
KR102122208B1 (ko) * 2020-04-07 2020-06-12 주식회사 라파스 마이크로니들 패치를 이용한 최소 침습적 아토피 피부염 검사 방법 및 마이크로니들 패치를 포함하는 최소 침습적 아토피 검사 키트
FR3109153B1 (fr) * 2020-04-10 2022-07-15 Teoxane SA Compositions à base d’au moins deux glycosaminoglycanes
KR20230024668A (ko) * 2021-08-12 2023-02-21 주식회사 페로카 마이크로니들 패치
CN114311721B (zh) * 2021-12-27 2023-09-08 青岛农业大学 一种可食用、可生物降解餐具的制备方法
KR102643334B1 (ko) * 2022-08-23 2024-03-05 주식회사 큐에이치바이오 가교 히알루론산 및 생체 적합성 미립자를 포함하는 피부 필러 조성물, 및 그 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7963997B2 (en) * 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
JP3420851B2 (ja) * 1994-12-06 2003-06-30 株式会社資生堂 癒着防止剤
JP4210231B2 (ja) * 2004-03-25 2009-01-14 株式会社資生堂 皮膚のシワを改善する美容方法及びシワ改善具
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
EP3415171B1 (en) * 2008-02-27 2022-12-14 3M Innovative Properties Company System and method for healing a wound at a tissue site
JP5267910B2 (ja) * 2008-02-28 2013-08-21 コスメディ製薬株式会社 マイクロニードルアレイ
US9320878B2 (en) 2008-10-07 2016-04-26 Tuo Jin Phase-transition polymeric microneedles
JP2013530785A (ja) * 2010-07-12 2013-08-01 シン・プーン・ファーマシューティカル・カンパニー・リミテッド 組織増大用充填組成物
CN104379020A (zh) * 2012-06-29 2015-02-25 Elc管理有限责任公司 包含一种或多种化妆品成分的微针
US10420921B2 (en) 2012-09-13 2019-09-24 Avraham Amir Delivery devices and methods for skin augmentation
KR101435888B1 (ko) * 2012-10-23 2014-09-01 연세대학교 산학협력단 히알루론산을 이용한 생분해성 마이크로니들 제조방법
MX2015008157A (es) * 2012-12-21 2016-02-22 Corium Int Inc Microarreglo para la entrega de agente terapeutico y metodos de uso.
CN104095761A (zh) * 2013-04-08 2014-10-15 上海汇林医药科技有限公司 一种高分子聚合物微针贴剂及其应用
JP6906885B2 (ja) * 2014-11-14 2021-07-21 ロレアル しわを減少させるためのマイクロニードルシート
MX2017010383A (es) 2015-02-13 2018-11-12 Endo Derma Co Ltd Microestructura usando hidrogel de ácido hialurónico reticulado y método para preparar el mismo.
CN104921961B (zh) * 2015-05-25 2017-11-17 成都凤磐生物科技有限公司 一种多效修复的可降解生物微针贴
US11285308B2 (en) * 2015-12-28 2022-03-29 Endoderma Co., Ltd. Microstructure for transdermal absorption and method for manufacturing same

Also Published As

Publication number Publication date
JP6900405B2 (ja) 2021-07-07
CN109310625A (zh) 2019-02-05
WO2017217818A1 (ko) 2017-12-21
TWI718576B (zh) 2021-02-11
EP3473242A1 (en) 2019-04-24
US11013670B2 (en) 2021-05-25
TW201938175A (zh) 2019-10-01
TW201808310A (zh) 2018-03-16
TWI675666B (zh) 2019-11-01
US20190336411A1 (en) 2019-11-07
KR20170142127A (ko) 2017-12-27
KR101973801B1 (ko) 2019-04-30
JP2019523680A (ja) 2019-08-29
EP3473242A4 (en) 2019-06-19
BR112018075703A2 (pt) 2019-04-02

Similar Documents

Publication Publication Date Title
MX2018015607A (es) Microestructura de acido hialuronico que tiene excelentes caracteristicas de solubilidad.
EP4279064A3 (en) Drug delivery from hydrogels
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
WO2016090287A3 (en) Transdermal cannabinoid formulations
EP4349414A3 (en) Methods and formulations for transdermal administration
MX2017003623A (es) Parche de opipramol.
MX2019014548A (es) Derivado de n2,n4-difenilprimidin-2,4-diamina, metodo para la preparacion del mismo, y una composicion farmaceutica que contiene el mismo como ingrediente activo para la prevencion o tratamiento de cancer.
CA3081755A1 (en) Therapeutic cannabinoid formulations and methods for their use
PH12015502280A1 (en) Transdermal delivery system comprising donepezil or its salt
GB2491328A (en) Immediate/delayed drug delivery
MX2022008277A (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
WO2015023649A3 (en) Peptides for enhancing transdermal delivery
NZ727709A (en) Pharmaceutical composition comprising 5alpha-reductase inhibitor
MX2011007817A (es) Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.
WO2018143552A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
WO2017176045A3 (ko) 효율적인 피부 천공을 위한 마이크로니들 구조
WO2013156488A3 (en) Optimised subcutaneous therapeutic agents
MX2017003638A (es) Microparticulas inyectables para liberacion hiper-localizada de agentes terapeuticos.
CA3010788A1 (en) Methods of administering vasopressors
MX2022006770A (es) Dispersiones solidas de bendamustina e infusion continua.
EP3587392A8 (en) Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
WO2016008401A8 (zh) 一种含多西他赛的药物组合物
EP3100744A4 (en) Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation
WO2014153643A8 (en) Compositions and methods for use thereof in the treatment of aniridia
EP3100743A4 (en) Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation